A 10-year retrospective study of interhospital patient transport using inhaled nitric oxide in Norway

Acta Anaesthesiologica Scandinavica
C BuskopM Sandberg

Abstract

Anaesthesiologists from Oslo University Hospital have transported patients with severe oxygenation failure with inhaled nitric oxide (usually 20 ppm) from other hospitals to a tertiary care centre since 2002 in an effort to reduce the number of patients that otherwise would require transport with ongoing extracorporeal membrane oxygenation. The aim of this study was to evaluate the patient safety during transport with inhaled nitric oxide. All patient transports with ongoing nitric oxide treatment undertaken from 2003 to 2012 were identified in the transport database. The frequency of adverse events and their impact on patient safety were studied in addition to response to inhaled nitric oxide and adjusted intensive care treatment and time aspects of the transports. Information about in-hospital treatment and survival were extracted from the hospital patient records. Adverse events were recorded in 12 of the 104 transports. Seven of the adverse events were due to malfunctioning technical equipment, three were related to medication other than the inhaled nitric oxide and two were related to ventilation. No adverse events resulted in permanent negative patient consequences or in discontinuation of the transport. Out of 104 patien...Continue Reading

References

Feb 11, 1993·The New England Journal of Medicine·R RossaintW M Zapol
Jul 15, 1993·The New England Journal of Medicine·M MonchiA T Dinh-Xuan
Nov 26, 2003·Intensive Care Medicine·Luca M Bigatello, Judith Hellman
Feb 18, 2004·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·B L DoringT Thayer
Sep 3, 2005·Critical Care : the Official Journal of the Critical Care Forum·Jack J M LigtenbergJan G Zijlstra
Mar 27, 2007·BMJ : British Medical Journal·Neill K J AdhikariMaureen O Meade
Feb 14, 2012·Critical Care : the Official Journal of the Critical Care Forum·Joep M DrooghJan G Zijlstra
Apr 17, 2013·Annals of Intensive Care·Erika Parmentier-DecrucqDaniel Mathieu

❮ Previous
Next ❯

Citations

Nov 30, 2016·Current Opinion in Critical Care·Onnen MoererMichael Quintel
Sep 24, 2020·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Peter Hilbert-CariusRoland Albrecht
Feb 24, 2019·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Per P BredmoseAnne Birthe Lømo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.